Medical News

RSS

Adding Cetuximab to chemo doubles response rate in hard-to-treat breast cancer

European researchers have proven for the first time that targeting the epidermal growth factor receptor can provide substantial clinical benefit for women with hard-to-treat triple-negative breast cancer.

11 Oct 2010

NovaSterilis Inc. and Cornell researcher Dr. CC Chu awarded a Metropolitan Development Association grant

NovaSterilis, Lansing NY, and Dr. CC Chu were awarded a grant from the Metropolitan Development Association (MDA) to explore the feasibility of utilizing NovaSterilis supercritical co2 sterilization for a variety of absorbable biomaterials from both commercial and experimental sources.

11 Oct 2010

Embryonic stem cells used in first trial for spinal cord injury

The first ever patient to receive treatment in a U.S. government approved study involving human embryonic stem cells has been injected with millions of the potentially life saving cells. He is presently being treated at the Shepherd Center in Atlanta. He was partially paralyzed following a spinal cord injury. The center specializes in treating these types of injuries.

11 Oct 2010

Baby born from 20 year old frozen embryo

A 42 year old mother gave birth to a baby born from an embryo frozen 20 years ago. This is the longest time a fertilized egg has been stored before developing into a healthy baby, and could eventually lead to thousands of women having children in middle age feel experts.

11 Oct 2010

Hospital staff go on 4 hour strike over pay issues

Hospital staff across Western Australia will strike today for better pay. The Industrial Relations Commission failed to assure the government that it would stop workers from carrying out industrial action. On Friday, the union rejected an offer to increase their weekly pay by $27.

11 Oct 2010

ZeroNines launches ZenVault Medical Personal Health Record portal

ZeroNines® Technology, Inc. announced the launch of ZenVault™ Medical, a Personal Health Record portal (PHR) that gives consumers instant, secure, private access to their medical records online. ZenVault Medical was specifically designed to address the public's concerns over data security, privacy, convenience, and expense associated with the national push to convert from traditional paper to digital medical records.

11 Oct 2010

Atomic Tattoos launches 'Tats for Tatas' breast cancer awareness fundraising campaign

Atomic Tattoos has announced the launch of their "Tats for Tatas" fundraising campaign that will take place throughout October, benefiting the Florida Breast Cancer Foundation in Florida and Southeast Regional Breast Cancer Fund in Wisconsin. In the company's concerted efforts to raise awareness and funds for Breast Cancer Awareness, Atomic Tattoos is offering several specials throughout the month if customers donate $5 to breast cancer awareness.

11 Oct 2010

Incentivized structured weight loss program with free prepared meals effectively promotes weight loss

In another article being released early online, Cheryl L. Rock, Ph.D., R.D., from Moores UCSD Cancer Center, La Jolla, Calif., and colleagues, conducted a randomized controlled trial of weight loss and weight maintenance in 442 overweight or obese women (BMI, 25 - 40), ages 18 to 69, over a two year period with follow-up between November 2007 and April 2010.

11 Oct 2010

New technologies and surgical techniques promise 'personalized' orthopedic operations

A number of new technologies and surgical techniques promise to "personalize" orthopedic operations such as hip and knee replacement, according to research to be presented at an educational program at Hospital for Special Surgery on October 15 and 16. During "Computer Assisted Orthopaedic Surgery: Review of Emerging Technologies," prominent orthopedic researchers will discuss how innovative technologies can improve surgical outcomes.

11 Oct 2010

DATATRAK signs agreement for three new Phase III oncology studies

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced the signing of an Enterprise Agreement for three new Phase III oncology studies with an existing client. These multi-center studies will be deployed utilizing the unified DATATRAK eClinical™ platform.

11 Oct 2010

Upward trend for post-breast feeding breast augmentation procedures

The Harley Medical Group, Ireland's leading cosmetic surgery provider, has revealed breast surgery is top of the ops for the 23rd year running and the fastest growing sector of cosmetic surgery. The Harley Medical Group has seen a positive increase on last year's enquiries. While breast reductions are becoming more popular with an increasing number of Irish women reducing their breast size in order to achieve a more slender figure, breast augmentation continues to be the most popular procedure performed at THMG's Dublin clinic.

11 Oct 2010

Access highlights clinical benefits of MuGard at ESMO conference

Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care, announced the highlights from a poster presentation on European clinical experience of MuGard at this year's European Society of Medical Oncology Conference in Milan, Italy.

11 Oct 2010

Persimmon Scientific to showcase antimicrobial nursing pads, hypoallergenic diaper liners at 8th ABC Kids Expo

Persimmon Scientific, Inc., dedicated to integrating technical and engineered fabrics into innovative, patentable medical products that promote skin comfort and improve quality of life, will be exhibiting at the First Timers Pavilion Booth #4439 and New Products Showcase at the upcoming ABC Kids Expo, the primary trade show for the juvenile products industry.

11 Oct 2010

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced the first results from the BALI-1 study of Erbitux® (cetuximab) in the treatment of metastatic triple-negative breast cancer (TNBC), an aggressive cancer in which early relapse and metastasis are common. The data, presented during the 35th Congress of the European Society for Medical Oncology (ESMO), demonstrate that Erbitux has the potential to improve outcomes for women with this relentlessly devastating cancer.

11 Oct 2010

Generex plans common stock rights offering

Generex Biotechnology Corporation today announced that it plans to initiate a rights offering of common stock and warrants to its existing stockholders in the event that the stockholders approve a reverse stock split at the reconvened special meeting of stockholders scheduled for 10 a.m. EDT on Friday, October 15, 2010.

11 Oct 2010

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Chongqing Cancer Hospital in Southwest China has become the first treatment center in Southwest China to offer cancer patients a faster, more precise form of image-guided radiotherapy that potentially enables doctors to improve outcomes while extending more advanced care to more patients. Clinicians at the hospital have used RapidArc® radiotherapy from Varian Medical Systems to treat patients for cancers of the nasopharynx, cervix, breast, and lung.

11 Oct 2010

Abbott presents data from 4 briakinumab pivotal studies in psoriasis

In four separate pivotal clinical studies presented on Friday, a greater percentage of moderate to severe chronic plaque psoriasis patients treated with briakinumab, Abbott's investigational IL-12/23 inhibitor (ABT-874), achieved 75 percent or better skin clearance rates than those treated with etanercept (Enbrel®), methotrexate or placebo. Abbott presented data from all briakinumab pivotal studies in psoriasis at the European Association of Dermatology and Venereology scientific sessions.

11 Oct 2010

Generex to acquire majority interest in Global Medical Direct

Generex Biotechnology Corporation today announced that it has entered into a definitive agreement to acquire a majority interest (51%) in Global Medical Direct, LLC of Lenexa, Kansas, a nationwide Durable Medical Equipment and Pharmaceutical provider specializing in direct-to-consumer diabetes supplies and medications.

11 Oct 2010

Obesity treatments falter, but researchers announce gene links

The Wall Street Journal: "An international research consortium says it has identified 18 new gene sites linked to obesity and 13 others associated with how fat is distributed in the body, advances that shed new light on the complex biology underlying one of the world's most pressing public-health problems. The findings are based on studies involving nearly 250,000 people, making the effort the largest so far to unravel the genetic basis of common human traits, researchers said.

11 Oct 2010

CTCA in Tulsa purchases BSD-2000 Hyperthermia System

BSD Medical Corporation announced today that the Cancer Treatment Centers of America (CTCA), located in Tulsa, Oklahoma, has purchased a BSD-2000 Hyperthermia System (BSD-2000). CTCA in Tulsa is a state-of-the-art hospital that is totally focused on treating cancer patients and provides the most advanced therapeutic resources in cancer treatment.

11 Oct 2010

Medical News

Adding Cetuximab to chemo doubles response rate in hard-to-treat breast cancer

NovaSterilis Inc. and Cornell researcher Dr. CC Chu awarded a Metropolitan Development Association grant

Embryonic stem cells used in first trial for spinal cord injury

Baby born from 20 year old frozen embryo

Hospital staff go on 4 hour strike over pay issues

ZeroNines launches ZenVault Medical Personal Health Record portal

Atomic Tattoos launches 'Tats for Tatas' breast cancer awareness fundraising campaign

Incentivized structured weight loss program with free prepared meals effectively promotes weight loss

New technologies and surgical techniques promise 'personalized' orthopedic operations

DATATRAK signs agreement for three new Phase III oncology studies

Upward trend for post-breast feeding breast augmentation procedures

Access highlights clinical benefits of MuGard at ESMO conference

Persimmon Scientific to showcase antimicrobial nursing pads, hypoallergenic diaper liners at 8th ABC Kids Expo

Merck Serono announces first results from Erbitux BALI-1 study in metastatic triple-negative breast cancer

Generex plans common stock rights offering

Chongqing Cancer Hospital commences treatment with Varian's RapidArc radiotherapy

Abbott presents data from 4 briakinumab pivotal studies in psoriasis

Generex to acquire majority interest in Global Medical Direct

Obesity treatments falter, but researchers announce gene links

CTCA in Tulsa purchases BSD-2000 Hyperthermia System

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News